EC Clinical and Medical Case Reports

Research Article Volume 6 Issue 1 - 2023

Upper Gastrointestinal Endoscopic Findings in Patients with Dyspeptic Symptoms and Upper Gastrointestinal Bleeding Whom Underwent Esophagogastroduodenoscopy in South Darfur State Sudan (Sep 2016 - Feb 2017)

Elmigdad Farah1*, Amin Mohamedm Abaas2 and Mysara Abakar Arbab3

1Assistant Consultant, Internal Medicine, King Faisal Specialist Hospital and Research Centre, Almadinah, KSA and Former Lecturer, Gezira University, Sudan

2Consultant Physician and Gastroenterologist, IBN SINA Specialized Hospital, Sudan

3Consultant Physician and Endoscopist, Nyala Teaching Hospital, Sudan

*Corresponding Author: Elmigdad Farah, Assistant Consultant, Internal Medicine, King Faisal Specialist Hospital and Research Centre, Almadinah, KSA and Former Lecturer, Gezira University, Sudan.
Received: December 06, 2022; Published: December 16, 2022



Background: Upper gastrointestinal endoscopy is the preferred investigative procedure for UGIB and dyspepsia because of its accuracy, low rate of complication, and its potential for therapeutic interventions.

Objective: To assess endoscopic findings in patients with dyspeptic symptoms and upper GI bleeding who underwent OGD.

Methods: The study is a descriptive, prospective study and hospital based was conducted in south Darfur state during the period (Sep 2016 - Feb 2017). The sample size was 216 patients diagnosed with dyspepsia and UGIB. Data was collected using a questionnaire which filled directly from the patients and from the endoscopic reports.

Results: Highest percentage of the patients 88 (40.7%) aged between 25 - 44 years, Male patients in the study sample were 123 (57%) while females were 93 (43%). Male to female ratio was 1.3:1. Indications for endoscopy were epigastric pain 164 (75.7%), indigestion and on 105 (48.7%), anemia 23 (10.6%), dysphagia 19 (8.6%), heart burn 18 (8.3%), hematemesis 9 (4.1%), melena 5 (2.3%). Reported causes of dyspepsia were gastritis 106 (49.07%), GERD 89 (41.2%), doudenititis 37 (17.1%), gastric ulcer represent 2 (0.92%), while malignancies were 7 (3.2%). Regarding causes of upper GI bleeding findings were esophageal avarices 9 (4.1%), P. HTN gastropathy 7 (3.24%), Duodenal ulcer 2 (0.92%), gastric tumor 1 (0.46%), normal endoscopy reported in 35 subjects (16.1%).

Conclusion: Upper GI endoscopy remain golden investigation in patients with dyspepsia and upper GI bleeding to determine the underlying pathology especially in whom have alarm features.

Keywords: GI Bleeding; GERD; Dyspepsia; Dysphagia; Gastritis; Peptic Ulcer Diseases; Duodenitis Esophageal Tumor; Gastric Cancer; Odynophagia; Portal Hypertension; Liver Cirrhosis

  1. Al-AssiMT., et al. Ulcer site and complications: relation to pylori infection and NSAIDs use endoscopy 28 (1996): 229-233.
  2. Lam KL., et al. “Pharmacological treatment in upper gasterointestinal bleeding”. Current Treatment Options in Gastroenterology 12 (2015): 369-376.
  3. Falla MA., et al. “Acute gastrointestinal bleeding”. Medical Clinic Names 84 (2000): 1183-1208.
  4. Heading RC. “Definition of dyspepsia”. Scandinavian Journal of Gastroenterology4 (2002): 1-6.
  5. Colin-jones D., et al. “Management of dyspepsia: report of a working party”. Lancet 1 (1988): 576-580.
  6. Tally NJ., et al. “Functional dyspepsia: a classification with guidelines for diagnosis and management”. Clinical Gastroenterologist International 4 (1991): 145-160.
  7. Kaul B., et al. “Gastroesoophageal reflux disease. Scintigraphic, endoscopic, and histologic considerations”. Scandinavian Journal of Gastroenterology 21 (1986): 134-138.
  8. Johnston BT., et al. “Are oesophageal symptoms reflux related. Study of different scoring systems in a cohort of patients with heartburn”. The American Journal of Gastroenterology 89 (1994): 597-502.
  9. Kingham JG., et al. “What is indigestion”. Journal of the Royal Society of Medicine 76 (2000): 183-186.
  10. Helman C. “Culture, health and illness”. Bristol: wright (1984).
  11. Agreus L and Tally NJ. “Challenges in managing dyspepsia in general practice”. British Medical Journal 315 (1997): 1284-1288.
  12. Value of the unaided clinical diagnosis in dyspeptic patients in primary care”. Annals of Gastroenterology5 (2001): 1417-1421.
  13. McColl KEL., et al. “Assessment of symptomatic response as predictor of H pylori status following eradication therapy in patients with ulcer”. Gut 42 (1998): 618-622.
  14. Johnsen R., et al. “Prevalence of endoscopic and histological findings in subjects with and without dyspepsia”. British Medical Journal 302 (1991): 749-752.
  15. Vakil N., et al. “Limited value of alarm features in diagnosis of upper gastrointestinal malignancies. Systemic review and meta- analysis”. Gastroenterology 131 (2006): 390-401.
  16. Fransen GA., et al. “Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy”. Alimentary Pharmacology and Therapeutics 20 (2004): 1045-1052.
  17. Moayyedi P., et al. “Can the clinical history distinguish between organic and functional dyspepsia”. The Journal of the American Medical Association 295 (2006): 1566-1576.
  18. Gasim B., et al. “Tropical gastroenterology”. Official Journal of the Digestive Disease Foundation 23 (2002): 107-109.

Elmigdad Farah et al. Upper Gastrointestinal Endoscopic Findings in Patients with Dyspeptic Symptoms and Upper Gastrointestinal Bleeding Whom Underwent Esophagogastroduodenoscopy in South Darfur State Sudan (Sep 2016 - Feb 2017). EC Clinical and Medical Case Reports   6.1 (2023): 35-41.